The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BLOCK LISTING SIX MONTHLY RETURN

15 Sep 2017 14:00

RNS Number : 9199Q
Dechra Pharmaceuticals PLC
15 September 2017
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Long-Term Incentive Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

21,507

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

174,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

195,507

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814730

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Approved Share Option Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

8,184

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

25,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

6,077

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

27,107

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Unapproved Share Option Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

65,972

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

55,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

23,254

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

97,718

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

SAYE Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

11,811

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

75,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

70,378

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

16,433

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRGGUQABUPMGPA
Date   Source Headline
15th Nov 20232:49 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Nov 20231:30 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
15th Nov 20231:11 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Nov 202311:55 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Nov 202311:49 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
15th Nov 202311:41 amRNSHolding(s) in Company
15th Nov 202310:41 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Nov 202310:39 amRNSForm 8.5 (EPT/RI)
15th Nov 202310:37 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:51 amRNSHolding(s) in Company
15th Nov 20239:21 amRNSForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
15th Nov 20239:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Nov 20239:19 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
15th Nov 20238:17 amRNSHolding(s) in Company
15th Nov 20238:16 amRNSHolding(s) in Company
15th Nov 20238:14 amRNSHolding(s) in Company
15th Nov 20237:34 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
14th Nov 20233:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
14th Nov 20233:14 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
14th Nov 20231:49 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
14th Nov 20231:26 pmPRNForm 8.3 - Dechra Pharmaceuticals PLC
14th Nov 20231:23 pmRNSForm 8.3 - DECHRA PHARMACEUTICALS PLC
14th Nov 202311:11 amRNSForm 8.3 - Dechra Pharmaceuticals plc
14th Nov 202311:06 amRNS2023 Notice of the Annual General Meeting
14th Nov 202310:24 amRNSForm 8.5 (EPT/RI)-Replacement of Dechra
14th Nov 202310:23 amRNSForm 8.5 (EPT/RI)
14th Nov 202310:19 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 202310:18 amRNSForm 8.5 (EPT/RI)-Replacement of Dechra
14th Nov 202310:17 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20239:10 amRNSForm 8.5 (EPT/NON-RI) Dehra Pharmaceuticals Plc
14th Nov 20238:53 amRNSForm 8.3 - Dechra Pharmaceuticals plc
14th Nov 20238:30 amRNSHolding(s) in Company
14th Nov 20238:30 amRNSHolding(s) in Company
14th Nov 20238:30 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
13th Nov 20232:30 pmPRNForm 8.3 - Dechra Pharmaceuticals Plc
13th Nov 20232:04 pmRNSForm 8.5 (EPT/RI)- Replacement of Dechra
13th Nov 20231:52 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
13th Nov 20231:48 pmRNSForm 8.5 (EPT/RI)
13th Nov 202312:54 pmPRNForm 8.3 - Dechra Pharmaceuticals plc
13th Nov 202312:44 pmRNSForm 8.3 - DECHRA PHARMACEUTICALS PLC
13th Nov 202312:10 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
13th Nov 202311:15 amRNSForm 8.3 - Dechra Pharmaceuticals plc
13th Nov 202310:23 amRNSForm 8.3 - Dechra Pharmaceuticals plc
13th Nov 202310:12 amRNSForm 8.5 (EPT/RI)
13th Nov 202310:09 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PL
13th Nov 20238:53 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
10th Nov 20234:36 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
10th Nov 20233:42 pmRNSHolding(s) in Company
10th Nov 20233:30 pmRNSForm 8.3 - DPH LN
10th Nov 20233:15 pmPRNForm 8.3 - Dechra Pharmaceuticals PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.